Structural basis for neutralizing antibody binding to pertussis toxin

被引:0
作者
Goldsmith, Jory A. [1 ]
Nguyen, Annalee W. [2 ]
Wilen, Rebecca E. [2 ]
Wijagkanalan, Wassana [3 ]
Mclellan, Jason S. [1 ]
Maynard, Jennifer A. [2 ]
机构
[1] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA
[2] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA
[3] BioNet Asia Co Ltd, Vaccine Discovery, Bangkok 10260, Thailand
关键词
antibody; pertussis; toxin; BORDETELLA-PERTUSSIS; PROTECTIVE ACTIVITIES; RECOGNITION; FORMALDEHYDE; VACCINES; COMPLEX;
D O I
10.1073/pnas.2419457122
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Pertussis toxin (PT) is a key protective antigen in vaccine-and natural immunity-mediated protection from Bordetella pertussis infection. Despite its importance, no PT-neutralizing epitopes have been characterized structurally. To define neutralizing epitopes and identify key structural elements to preserve during PT antigen design, we determined a 3.6 & Aring; cryoelectron microscopy structure of genetically detoxified PT (PTg) bound to hu11E6 and hu1B7, two potently neutralizing anti-PT antibodies with complementary mechanisms: disruption of toxin adhesion to cells and intracellular activities, respectively. Hu11E6 binds the paralogous S2 and S3 subunits of PTg via a conserved epitope but surprisingly did not span the previously identified sialic acid-binding site implicated in toxin adhesion. Hu11E6 specifically prevented PTg binding to sialylated N-glycans and a sialylated model receptor, as demonstrated by high-throughput glycan array analysis and ELISA, while a T cell activation assay showed that it blocks PTg mitogenic activities to define its neutralizing mechanism. Hu1B7 bound a quaternary epitope spanning the S1 and S5 subunits, although functional studies of hu1B7 variants suggested that S5 binding is not involved in its PT neutralization mechanism. These results structurally define neutralizing epitopes on PT, improving our molecular understanding of immune protection from B. pertussis and providing key information for the future development of PT immunogens.
引用
收藏
页数:9
相关论文
共 58 条
[1]   Humanised monoclonal antibodies neutralise pertussis toxin by receptor blockade and reduced retrograde trafficking [J].
Acquaye-Seedah, Edith ;
Huang, Yimin ;
Sutherland, Jamie N. ;
DiVenere, Andrea M. ;
Maynard, Jennifer A. .
CELLULAR MICROBIOLOGY, 2018, 20 (12)
[2]   Asymptomatic transmission and the resurgence of Bordetella pertussis [J].
Althouse, Benjamin M. ;
Scarpino, Samuel V. .
BMC MEDICINE, 2015, 13
[3]   Genetically detoxified pertussis toxin displays near identical structure to its wild-type and exhibits robust immunogenicity [J].
Ausar, Salvador F. ;
Zhu, Shaolong ;
Duprez, Jessica ;
Cohen, Michael ;
Bertrand, Thomas ;
Steier, Valerie ;
Wilson, Derek J. ;
Li, Stephen ;
Sheung, Anthony ;
Brookes, Roger H. ;
Pedyczak, Artur ;
Rak, Alexey ;
James, D. Andrew .
COMMUNICATIONS BIOLOGY, 2020, 3 (01)
[4]   Complete Genome Sequences of 11 Bordetella pertussis Strains Representing the Pandemic ptxP3 Lineage [J].
Bart, Marieke J. ;
van der Heide, Han G. J. ;
Zeddeman, Anne ;
Heuvelman, Kees ;
van Gent, Marjolein ;
Mooi, Frits R. .
GENOME ANNOUNCEMENTS, 2015, 3 (06)
[5]   MAPPING OF A PROTECTIVE EPITOPE OF PERTUSSIS TOXIN BY INVITRO REFOLDING OF RECOMBINANT FRAGMENTS [J].
BARTOLONI, A ;
PIZZA, M ;
BIGIO, M ;
NUCCI, D ;
ASHWORTH, LA ;
IRONS, LI ;
ROBINSON, A ;
BURNS, D ;
MANCLARK, C ;
SATO, H ;
RAPPUOLI, R .
BIO-TECHNOLOGY, 1988, 6 (06) :709-712
[6]  
Brown PI, 2023, ENG MICROBIOL, V3, DOI [10.1016/j.engmic.2023.100104, 10.1016/j.engmic.2023.100104]
[7]   Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange [J].
Buasri, Wasin ;
Impoolsup, Attawut ;
Boonchird, Chuenchit ;
Luengchaichawange, Anocha ;
Prompiboon, Pannipa ;
Petre, Jean ;
Panbangred, Watanalai .
BMC MICROBIOLOGY, 2012, 12
[8]   Pertussis leukocytosis: mechanisms, clinical relevance and treatment [J].
Carbonetti, Nicholas H. .
PATHOGENS AND DISEASE, 2016, 74 (07)
[9]   A search for serologic correlates of immunity to Bordetella pertussis cough illnesses [J].
Cherry, JD ;
Gornbein, J ;
Heininger, U ;
Stehr, K .
VACCINE, 1998, 16 (20) :1901-1906
[10]   Acellular pertussis vaccines containing genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults [J].
DiTommaso, A ;
Bartalini, M ;
Peppoloni, S ;
Podda, A ;
Rappuoli, R ;
DeMagistris, MT .
VACCINE, 1997, 15 (11) :1218-1224